Saw Palmetto 160 mg by Nature's Way — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size

Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Saw Palmetto extract

160 mg

📊 Market median: 320.0mg (426 products) 📚 24 studies (Tier A: 0, B: 5)

This product: 160mg

Other Ingredients

Olive Oil Gelatin Glycerin purified Water

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (98% of products) Structure/Function (83% of products) Nutrient (17% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Recommendation: Take 1 softgel twice daily, preferably with food.

⚠️ Warnings & Precautions

If you are taking any medication, consult a healthcare professional before use. Not intended for use by pregnant or nursing women.

Keep out of reach of children.

Safety sealed with printed inner seal. Do not use if seal is broken or missing.

🧪 Formulation Notes

Supports prostate health

Saw Palmetto berries grow in only one place in the entire world: the Florida Everglades. Nature’s Way partners with harvesters to ensure only ripe berries are sourced.

Saw Palmetto 160 mg per serving

Gluten free. No salt, yeast-derived ingredients, wheat, corn, soy, dairy products, or artificial colors, flavors, or preservatives.

Premium extract

Additional Information

Nature’s Way Since 1969

Bottles made From 97% Post-consumer Recycled plastic

Quality Global Sourcing Bottled & Tested In the USA

Product Details

UPC / SKU 7 63948 08360 2

DSLD Entry Date 2020-01-25

Product Type Botanical

Form Softgel Capsule

Brand Nature's Way

DSLD ID 212783

Data Updated 2026-04-11

Research Evidence

35 Research Sources

52 Avg Quality Score

15 Meta Analysis

11 Systematic Review

7 Rct

1 Narrative Review

1 Openfda Safety

B Serenoa repens for benign prostatic hyperplasia

Meta Analysis The Cochrane database of systematic reviews 2009

PubMed DOI

B Serenoa repens for benign prostatic hyperplasia

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI

B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis

Meta Analysis Investigative and clinical urology 2021

PubMed DOI

B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials

Systematic Review European urology focus 2021

PubMed DOI

B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene

Systematic Review European review for medical and pharmacological sciences 2019

PubMed DOI

B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

Meta Analysis American journal of men's health 2020

PubMed DOI

B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review

Systematic Review BJU international 2012

PubMed DOI

B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis